arrow
L

Luca Mastrantoni

università cattolica del sacro cuore
H指数:8
被引数:297

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-analyte liquid biopsy characterization of metastatic inflammatory breast cancer: comparison with non-inflammatory breast cancer

多指标液体活检对转移性炎性乳腺癌的表征:与非炎性乳腺癌的比较

2026-08-060
OA
Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors

HER2+/HR+乳腺癌的下一个前沿:利用细胞周期调控CDK4/6抑制剂

2026-03-040
OAAI
Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer

通过NGS进行微卫星不稳定性分析及通过IHC进行错配修复缺陷分析在子宫内膜癌和结直肠癌中的应用

2026-02-250
OAAI
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

破译上皮性卵巢癌的脑转移: 多模态分析和潜在的生物标志物

2026-01-190
OAAI
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer

根据分子靶点临床可操作性量表(ESCAT)评估的,无特定分子特征(NSMP)子宫内膜癌的基因可操作性

2025-09-030
OAAI
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib

NRG1变异体不确定意义(VUSes)在晚期非小细胞肺癌中的网络分析及其在EGFR突变患者接受一线奥希替尼治疗中的预后作用

2025-08-290
OAAI
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery

整合临床-分子数据以预测接受间隔肿瘤细胞减灭术的晚期卵巢癌患者对PARP抑制剂的疗效

2025-04-010
OAAI
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study

根据HER2评分(低 vs. 评分0)的激素受体阳性HER2阴性早期乳腺癌新辅助化疗的活性与疗效:一项回顾性研究

2025-03-050
PRE
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
2025-02-050
OA
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism

评估Khorana评分和基因组分析在卵巢癌相关静脉血栓栓塞中的预测作用

2025-02-010
PRE
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression

深入探讨无特定分子谱(NSMP)子宫内膜癌:根据雌激素受体(ER)表达解析基因组特征

2025-02-010
PRE
Comprehensive Genomic Profiling (CGP) In Epithelial Ovarian Cancer: Biomarker Prevalence Across Different Histotypes

上皮性卵巢癌中的综合基因组分析(CG P):不同组织学类型的生物标志物流行率

2025-02-010
PRE